Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Patients' characteristics | Download Table
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
REMARK diagram for biomarker studies. | Download Scientific Diagram
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
PDF) A multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
PDF) A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis BOUKOVINAS | Bioclinic Thessaloniki, Thessaloníki | Oncology Unit
PDF) Case-Mix Adjustment Approach to Benchmarking Prevalence Rates of Nosocomial Infection in Hospitals in Cyprus and Greece
Overall survival by RDI. Kaplan Meier overall survival curve for... | Download Scientific Diagram
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Œ½¼± •€¯¸µ„ ±½/¼¹ Athanasios Krystallis Aarchus Univ ... Athanasios Krystallis
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
I. Varthalitis's research works | Hellenic Cooperative Oncology Group, Athens (HeCOG) and other places
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Spatial variation of micro-void excess water pressure at x=0 at Tv=0.1,... | Download Scientific Diagram
a Number of delayed cycles (\2 cycles, C2 cycles), b number of delayed... | Download Scientific Diagram
Univariate and Multivariate Analysis of Risk Factors for Mortality... | Download Table
Effects of caspase inhibitors and thiol supplements on doxorubicin... | Download Scientific Diagram
Endogenous and Exogenous Risk Factors of Patients Surveyed for... | Download Table
